Detalhe da pesquisa
1.
Radiation therapy dose escalation achieves high rates of local control with tolerable toxicity profile in pediatric and young adult patients with Ewing sarcoma.
Cancer
; 130(10): 1836-1843, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271232
2.
Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332.
Pediatr Blood Cancer
; : e31062, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38757485
3.
Regional lymph node evaluation in pediatric conventional melanoma subtype: a single-center 10-year review.
Pediatr Surg Int
; 40(1): 68, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441654
4.
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(8): 851-880, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549914
5.
Germline genomic findings in children and young adults with melanocytic tumors.
Pediatr Blood Cancer
; 70(7): e30361, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37073685
6.
Feasibility of indocyanine green-guided localization of pulmonary nodules in children with solid tumors.
Pediatr Blood Cancer
; 70(10): e30437, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37194488
7.
Top advances of the year: Pediatric oncology.
Cancer
; 128(20): 3593-3596, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36074012
8.
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.
J Natl Compr Canc Netw
; 20(11): 1204-1214, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36351335
9.
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(7): 815-833, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35830886
10.
A prospective, comprehensive registry that integrates the molecular analysis of pediatric and adolescent melanocytic lesions.
Cancer
; 127(20): 3825-3831, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228365
11.
Pain and functional outcomes in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort study.
Cancer
; 127(10): 1679-1689, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33369896
12.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
N Engl J Med
; 378(8): 731-739, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29466156
13.
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
Lancet Oncol
; 21(1): 145-161, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31786124
14.
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
Lancet Oncol
; 21(4): 531-540, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32105622
15.
Desmoplastic Small Round Cell Tumor: Long-Term Complications After Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol
; 27(1): 171-178, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963398
16.
NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021.
J Natl Compr Canc Netw
; 18(12): 1604-1612, 2020 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33285515
17.
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.
Lancet Oncol
; 19(5): 705-714, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29606586
18.
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.
Cancer
; 124(21): 4241-4247, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30204247
19.
Germline Mutations in Predisposition Genes in Pediatric Cancer.
N Engl J Med
; 373(24): 2336-2346, 2015 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26580448
20.
Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous.
Acta Neuropathol
; 136(2): 315-326, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29428974